FDA Considers Spring COVID Booster for At-Risk Adults and Immunocompromised

The FDA may authorize a second booster with the bivalent vaccines for at least some people, such as those who are at high risk because they have compromised immune systems or are 65 and older. A decision could be announced within weeks. The main concern is the protection people got from their last shot has been fading, not just against getting infected but also possibly against getting seriously ill. Some vaccine specialists have been urging for a second booster, especially with the ample supply of vaccine available. However, some scientists aren't so sure, saying there isn't any good evidence showing protection against serious illness has faded significantly or that getting another shot would help that much.